Archer Daniels Midland Company - ADM STOCK NEWS

ADM reported net earnings of $1.2 billion for the quarter ending March 31, 2023, showcasing a significant year-over-year increase in earnings per share of $2.12 compared to $1.86 in 2022. Adjusted earnings per share also saw a rise to $2.09 from $1.90. The company benefitted from higher demand in its Ag Services & Oilseeds and Carbohydrate Solutions segments, achieving a segment operating profit of $1.719 billion. Notably, Ag Services results were bolstered by a record Brazilian soybean crop, while Carbohydrate Solutions faced margin pressures in ethanol. The Nutrition segment encountered challenges, particularly in Animal Nutrition, leading to significantly lower year-over-year results. ADM maintains a strong balance sheet, positioning itself for continued investment in growth strategies.

Harpe Bioherbicide Solutions, Inc., based in North Carolina, has successfully closed a $10.5 million funding round led by ADM (NYSE: ADM). This investment aims to bolster the R&D of Harpe's innovative portfolio of natural herbicides, enhancing their commercial viability. The funds will also support the development of herbicide-tolerant row crop systems, contributing to Harpe's intellectual property expansion. This collaboration fits within ADM's sustainability strategy, highlighting their commitment to innovative agricultural solutions. With the introduction of plant-based herbicides, the partnership aims to tackle growing weed resistance challenges and promote sustainable farming practices.

ADM has signed a non-exclusive memorandum of understanding (MOU) with Believer Meats to enhance the development and commercialization of cultivated meat products. This initiative comes as the global population is projected to reach 10 billion by 2050, highlighting the urgent need for sustainable food sources.

According to Leticia Gonçalves, ADM’s president of Global Foods, 70% of consumers are aware of cultivated meat, with flexitarians representing over half of the market. This collaboration aims to meet the growing demand for diverse protein choices and enhance food security.

The MOU outlines plans to leverage ADM’s extensive ingredient expertise and processing capabilities to support Believer’s scalable meat production technology, fostering innovation within the cultivated meat sector.

ADM is set to announce its financial results for Q1 2023 on April 25, 2023, prior to market opening. A webcast is scheduled for 8 a.m. Central Time to discuss these results and offer a company update. Investors can access the webcast and presentation slides via www.adm.com/webcast. As a leader in human and animal nutrition, ADM aims to provide innovative solutions that enhance the quality of life while focusing on sustainability and future-oriented products. The company emphasizes its role in improving health and well-being through groundbreaking developments and is actively working to decarbonize its industry.

ADM has nominated Dr. Ellen de Brabander for election to its Board of Directors at the upcoming Annual Stockholders’ Meeting on May 4, 2023. Currently the executive vice president for Innovation and Regulatory Affairs at Elanco, de Brabander brings significant expertise in human nutrition and animal health. Chairman and CEO Juan Luciano emphasized her role in strengthening ADM's growth potential through her extensive experience in R&D. Additionally, the company announced the retirement of Lead Director Don Felsinger at age 75 and Francisco Sanchez's decision not to stand for re-election, marking a transition in the board's leadership.

ADM has opened a new production facility in Valencia, Spain, with an investment exceeding $30 million. This strategic move increases ADM's production capacity by over five times to 50 metric tons per year, addressing rising global demand for probiotics and postbiotics.

The facility is set to support ADM's growth strategy in the health and well-being sector, with the potential to triple its customer base in the next five years. ADM aims to boost health and wellness revenue from $500 million in 2022 to $2 billion by 2032.